Are you sure?

HUPHAR names cariprazine ʼ2019 Medicine of the Yearʼ

The Hungarian Society for Experimental and Clinical Pharmacology (HUPHAR) has named Gedeon Richterʼs antipsychotic cariprazine "2019 Medicine of the Year", according to a report by state news wire MTI.

At a ceremony late Thursday, HUPHAR chairman Péter Ferdinandy said cariprazine is the first "genuine" Hungarian drug, discovered and developed by Richter researchers, in many years. The drug has gained a foothold on global markets and has a "great future" ahead of it, he added.

Richter chairman Erik Bogsch noted that cariprazine, the product of 18 years of research, is the first Hungarian-developed original preparation to be introduced on the United States market.

Cariprazine, marketed under the brand names Vraylar and Reagila, was Richterʼs second best-selling drug last year, generating a turnover of HUF 57.7 billion.